Omentin inhibits the resistin‑induced hypertrophy of H9c2 cardiomyoblasts by inhibiting the TLR4/MyD88/NF‑κB signaling pathway

Xiaoliang Yan(Shanxi Medical University), Yongzhi Deng(Shanxi Cardiovascular Hospital)
Experimental and Therapeutic Medicine
February 17, 2022
Cited by 11


Related Papers